非卧床持续性腹膜透析治疗糖尿病肾病性尿毒症患者56例的临床报告  

OBSERVATION ON THE CLINICAL EFFECT OF CONTINUOUS AMBULATORY PERITONEAL DIALYSIS ON DIABETIC NEPHROPATHY UREMIA OF 56 PATIENTS

作　　者：李梅茹 侯淑芬[2] 

机构地区：[1]河北定州市省第七人民医院内二科,定州073000 [2]保定市河北大学附属医院肾内科

出　　处：《现代预防医学》2006年第7期1279-1280,共2页Modern Preventive Medicine

摘　　要：目的:探讨糖尿病肾病尿毒症患者腹膜透析的临床疗效。方法:对56例糖尿病肾病尿毒症患者进行非卧床持续性腹膜透析(CAPD)治疗,观察CAPD前后的生活质量和血液生化检验指标、生存率、主要并发症等。结果:CAPD可显著改善患者尿毒症症状及重要血液生化检验指标,提高生活质量,血糖控制良好。结论:CAPD治疗糖尿病肾病尿毒症安全有效,腹腔给胰岛素血糖控制良好,可在家中进行透析,患者生活质量较高。Objective： To investigate the clinical effect of CAPD to patients with Diabetic nephropathy uremia.Methods： 56 patients with Diabetic nephropathy Uremia were treated by CAPD, observing the survival rate main complications. Clinical and biochemical standards etc. Results： CAPD can significantly improve Uremia symptoms and main biochemical standards, control serum glucose well.Conclusion： CAPD to Diabetic nephropathy is secure and effective, which can be done at home.The life quality is high.

关 键 词：尿毒症 糖尿病肾病 非卧床持续性腹膜透析 

分 类 号：R587[医药卫生—内分泌]